Metformin: Sex/Gender Differences in Its Uses and Effects-Narrative Review.
Ioannis IliasManfredi RizzoLina ZabulienePublished in: Medicina (Kaunas, Lithuania) (2022)
Metformin (MTF) occupies a major and fundamental position in the therapeutic management of type 2 diabetes mellitus (T2DM). Gender differences in some effects and actions of MTF have been reported. Women are usually prescribed lower MTF doses compared to men and report more gastrointestinal side effects. The incidence of cardiovascular events in women on MTF has been found to be lower to that of men on MTF. Despite some promising results with MTF regarding pregnancy rates in women with PCOS, the management of gestational diabetes, cancer prevention or adjunctive cancer treatment and COVID-19, most robust meta-analyses have yet to confirm such beneficial effects.
Keyphrases
- cardiovascular events
- polycystic ovary syndrome
- pregnancy outcomes
- meta analyses
- coronary artery disease
- systematic review
- coronavirus disease
- cardiovascular disease
- sars cov
- papillary thyroid
- randomized controlled trial
- middle aged
- pregnant women
- squamous cell carcinoma
- insulin resistance
- metabolic syndrome
- breast cancer risk
- childhood cancer